ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.154,79
0,44%
S&P 500
5.221,42
-0,02%
US Dollar vs BRL
5,1551
-0,01%
Bitcoin
61.841,83
-1,69%
Brent Oil
83,14
-0,08%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Coya Therapeutics Inc (COYA)

  7. Coya Therapeutics Inc (COYA) Notícias

COYA Coya Therapeutics Inc

8,08
0,00 (0,00%)
13 Mai 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Coya Therapeutics Inc COYA NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
Upgrade Icon
0,00 0,00% 8,08 21:00:00
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
8,08
mais cotações »

Notícias Recentes

Data Hora Fonte Título
09/05/202417:10BWCoya Therapeutics Provides a Corporate Update and Reports..
26/04/202409:15BWCoya Therapeutics Presents Updated ALS Biomarker Data at the..
22/04/202409:15BWCoya Therapeutics to Participate in the Mizuho Neuroscience..
18/04/202409:15BWCoya Therapeutics to Participate in the 3rd Annual ALS Drug..
08/04/202409:15BWCoya Therapeutics Scientific Advisory Board Chairman Dr...
19/03/202409:15BWCoya Therapeutics Provides a Corporate Update and Reports..
12/03/202410:00BWCoya Therapeutics to Participate in BTIG Fireside Discussion
12/03/202409:00BWCoya Therapeutics Presents ALS Biomarker Data at Society of..
06/03/202410:15BWCoya Therapeutics Presents Biomarker Data on..
29/02/202410:15BWCoya Therapeutics to Present Data on Immune System and..
22/02/202410:15BWCoya Therapeutics to Present Novel Biomarker Survival Data..
21/02/202410:15BWCoya Therapeutics Issues Letter to Stockholders Highlighting..
13/02/202410:15BWCoya Therapeutics Licenses Intellectual Property Rights for..
29/01/202410:15BWCoya Therapeutics SAB Chairman Dr. Stanley Appel, M.D...
18/01/202410:15BWCoya Therapeutics to Participate in Upcoming Chardan Biotech..
16/01/202410:15BWCoya Therapeutics Announces Pipeline Expansion of COYA 302..
16/01/202406:06PRNUSDISCO Pharmaceuticals launches as the surfaceome company..
16/01/202405:59PRNUSDISCO Pharmaceuticals launches as the surfaceome company..
05/01/202410:00BWCoya Therapeutics Announces Successful Pre-IND and Type C..
20/12/202310:30BWMr. Wilbur L. Ross, Former United States Secretary of..
13/12/202310:00BWCoya Therapeutics’ CEO Dr. Howard Berman’s Letter to..
12/12/202310:00BWCoya Therapeutics Announces Closing of $26.5 Million Private..
06/12/202309:05BWCoya Therapeutics Announces $26.5 Million Private Placement
06/12/202309:00BWCoya Therapeutics, Inc. and Dr. Reddy’s Laboratories Enter..
08/11/202311:00BWCoya Therapeutics, Inc. Provides Business Update and Reports..
27/10/202310:00BWCoya Announces Acceptance of Oral Presentation, “Regulatory..
09/10/202309:00BWCoya Therapeutics (Coya) Announces Completion of Enrollment..
05/10/202310:00BWCoya Therapeutics Presents New Experimental Data Supporting..
03/10/202310:00BWCoya Therapeutics Announces the Presentation of Human..
27/09/202310:00BWCoya Therapeutics to Present at the LD Micro Investor..
22/09/202310:00BWCoya Therapeutics Licenses Exclusive Worldwide rights to..
07/09/202310:15BWCoya Therapeutics Successfully Engineers Regulatory T Cell..
31/08/202309:00BWCoya Therapeutics Announces Publication of Potential Novel..
25/08/202310:00BWCoya Therapeutics To Present Novel Proof of Concept Exosome..
21/08/202308:00BWFormer CEO and Chairman of the Board of Bayer Pharma AG,..
08/08/202308:00BWCoya Therapeutics, Inc. Provides Business Update and Reports..
03/08/202308:00BWCoya Therapeutics to Present at the BTIG Virtual..
19/07/202308:00BWCoya Therapeutics (“Coya”) Announces the Appointment of Dr...
17/07/202308:00BWCoya Therapeutics Reports Additional Proof-of-Concept..
05/07/202309:30BWCoya Therapeutics (“Coya”) Appoints Industry and Drug..
28/06/202308:00BWCoya Therapeutics to Present Proof-of-Concept Clinical Data..
20/06/202308:00BWCoya Therapeutics, Inc. (Coya) Broadens its COYA 300..
14/06/202308:00BWCoya Therapeutics Strengthens its Management Team with the..
12/06/202308:00BWCoya Therapeutics’ CEO Dr. Howard Berman’s Letter to..
07/06/202308:00BWCoya Therapeutics Reports Additional Blood Biomarker and..
05/06/202308:00BWCoya Therapeutics Strengthens Scientific Advisory Board..
22/05/202308:00BWCoya to Present Additional Biomarker and Brain Imaging Data..
16/05/202308:00BWCoya Therapeutics’ COYA 301 Increased Treg Function and..

Seu Histórico Recente

NASDAQ
COYA
Coya Therapeutics
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados